Diaphorina citri psyllid: psy11399


Local Sequence Feature Prediction

Prediction and MethodResult
Residue Number Marker
Protein Sequence ?
Secondary Structure (Consensus) ?
Disordered Region (Consensus) ?
Transmembrane Helix (Consensus) ?
Signal Peptide (Consensus) ?
Coiled Coil (COILS) ?
 
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820-------830-------840-------850-------860-----
MAIPFPTTPDISNDLNFGNSIFTCGGQTKCAGAPPPGAPGAPPGPVAPPGAVPAPPGAMGLIPPNQPPQPVQPPELPMFNCPRRPNLGREGRPIVLRANHFQISMPRGFVHHYEIQIQPDKCPRKVNREIIETMVHAYSKIFGALKPVFDGRNNLYTRDPLPIGNDRMELEVTLPGEGKDRVFRVAIKWQAQVSLFALEEALEGRTRQIPFDAILALDVVMRHLPSMTYTPVGRSFFSTPDGYYHPLGGGREVWFGFHQSVRPSQWKMMLNIDVSATAFYKSQPVIEFMCEVLDIRDVNEQRKPLTDSQRVKFTKEIKGLKIEITHCGTMKRKYRVCNVTRRPAQMQSFPLQLENGQTVECTVAKYFLDKYKMKLRFPHLPCLQVGQEHKHTYLPLEVCNIVAGQRCIKKLTDMQTSTMIKATARSAPDREREIQSLVKRADFNNDAYVHEFGLTISNSMMEVRGRVLPPPKLQYGGRMSSITAQVNSMSSQGLFASKQQALPNSGVWDMRGKQFYTGVEIRVWAIACFAPQRTVREDSLRSFTQQLQKISNDAGMPIIGQPCFCKYATGPDQVEPMFRYLKSTFQALQLVVVVLPGKTPVYAEVKRVGDTVLGMATQCVQAKNVNKTSPQTLSNLCLKINVKLGGINSILVPSIRPKVFNEPVIFMGADVTHPPAGDNKKPSIAAVVGSMDAHPSRYAATVRVQQHRQEIIQELSSMVRLFCADKKEQSGKSGNIPAGTTVDIGITHPTEFDFYLCSHQGIQGTSRPSHYHVLWDDNHFDADELQCLTYQLCHTYVRCTRSVSIPAPAYYAHLVAFRARYHLVEKEHDSGEGSHQSGSSEDRTPGAMARAITVHADTKKVMYFA
cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEEEEEEEEcccccEEEEEEEEcccccccHHHHHHHHHHHHHHHHHHccccCEECcccCEECccccccccccEEEEEEcccccccEEEEEEEEEEEEEcHHHHHHHHccccccccHHHHHHHHHHHHHcccccccccccccccccccccccccccEEEEcccCEEEECcccCEEEEcccccccccccccHHHHHHHHHcccccccccccccHHHHHHccccEEccEEEEEcccccccEEEEEcccccccccccccccccccccEEEEHHHHHHHHcccccccccccCEECcccccccccccccEEEcccccccccccHHHHHHHHHHHHccHHHHHHHHHHHHHHccccccHHHHccccEEcccEEEEEEEECccccEEEcccccccccccccccccccccccccccccccEEEccccEEcccccccEEEEEECcccccccHHHHHHHHHHHHHHHHHccccccccccccccccccccHHHHHHHHHHHccccEEEEEEEcccccccccEEEEEEEEcccEEEEECccccccccHHHHHHHHHHHHccccccCEEEccccccccccccEEEEEEECcccccccccccHHHHHHHccccccccccEEEEEcccHHHHHHHHHHHHHHHHHHHHHHcccccccccEEEEEEcccccccEEEEEEccccccccccccCEEEEEcccccccHHHHHHHHHHHHHHHcccccccccccHHHHHHHHHHHHccccccccccccccccccccccccccHccccccccccccccEEEc
*****************************************************************************************EGRPIVLRANHFQISMPRGFVHHYEIQIQPDKCPRKVNREIIETMVHAYSKIFGALKPVFDGRNNLYTRDPLPIGNDRMELEVTLPGEGKDRVFRVAIKWQAQVSLFALEEALEGRTRQIPFDAILALDVVMRHLPSMTYTPVGRSFFSTPDGYYHPLGGGREVWFGFHQSVRPSQWKMMLNIDVSATAFYKSQPVIEFMCEVLDIRDVNEQRKPLTDSQRVKFTKEIKGLKIEITHCGTMKRKYRVCNVTRRPAQMQSFPLQLENGQTVECTVAKYFLDKYKMKLRFPHLPCLQVGQEHKHTYLPLEVCNIVAGQRCIKKLTDM*****I*ATARSAPDREREIQSLVKRADFNNDAYVHEFGLTISNSMMEVRGRVLPPPKLQYGGRMSSITAQVNSMSSQGLFASKQQALPNSGVWDMRGKQFYTGVEIRVWAIACFAPQRTVREDSLRSFTQQLQKISNDAGMPIIGQPCFCKYATGPDQVEPMFRYLKSTFQALQLVVVVLPGKTPVYAEVKRVGDTVLGMATQCVQAKNVNKTSPQTLSNLCLKINVKLGGINSILVPSIRPKVFNEPVIFMGADVTHP*******PS*AAVVGSMDAHPSRYAATVRVQQHRQEIIQELSSMVRLFCADKKEQSGKSGNIPAGTTVDIGITHPTEFDFYLCSHQGIQGTSRPSHYHVLWDDNHFDADELQCLTYQLCHTYVRCTRSVSIPAPAYYAHLVAFRARYHLV***************************ITVHADTKKVMYFA
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
MAIPFPTTPDISNDLNFGNSIFTCGGQTKCAGAPPPGAPGAPPGPVAPPGAVPAPPGAMGLIPPNQPPQPVQPPELPMFNCPRRPNLGREGRPIVLRANHFQISMPRGFVHHYEIQIQPDKCPRKVNREIIETMVHAYSKIFGALKPVFDGRNNLYTRDPLPIGNDRMELEVTLPGEGKDRVFRVAIKWQAQVSLFALEEALEGRTRQIPFDAILALDVVMRHLPSMTYTPVGRSFFSTPDGYYHPLGGGREVWFGFHQSVRPSQWKMMLNIDVSATAFYKSQPVIEFMCEVLDIRDVNEQRKPLTDSQRVKFTKEIKGLKIEITHCGTMKRKYRVCNVTRRPAQMQSFPLQLENGQTVECTVAKYFLDKYKMKLRFPHLPCLQVGQEHKHTYLPLEVCNIVAGQRCIKKLTDMQTSTMIKATARSAPDREREIQSLVKRADFNNDAYVHEFGLTISNSMMEVRGRVLPPPKLQYGGRMSSITAQVNSMSSQGLFASKQQALPNSGVWDMRGKQFYTGVEIRVWAIACFAPQRTVREDSLRSFTQQLQKISNDAGMPIIGQPCFCKYATGPDQVEPMFRYLKSTFQALQLVVVVLPGKTPVYAEVKRVGDTVLGMATQCVQAKNVNKTSPQTLSNLCLKINVKLGGINSILVPSIRPKVFNEPVIFMGADVTHPPAGDNKKPSIAAVVGSMDAHPSRYAATVRVQQHRQEIIQELSSMVRLFCADKKEQSGKSGNIPAGTTVDIGITHPTEFDFYLCSHQGIQGTSRPSHYHVLWDDNHFDADELQCLTYQLCHTYVRCTRSVSIPAPAYYAHLVAFRARYHLVEKEHDSGEGSHQSGSSEDRTPGAMARAITVHADTKKVMYFA

Function Prediction

Annotation transfered from Closely Related SWISS-PROT Entries ?

Annotation ?Function Description ?Confidence Level ?Reference Protein ?
Protein argonaute-2 Required for RNA-mediated gene silencing (RNAi) by the RNA-induced silencing complex (RISC). The 'minimal RISC' appears to include EIF2C2/AGO2 bound to a short guide RNA such as a microRNA (miRNA) or short interfering RNA (siRNA). These guide RNAs direct RISC to complementary mRNAs that are targets for RISC-mediated gene silencing. The precise mechanism of gene silencing depends on the degree of complementarity between the miRNA or siRNA and its target. Binding of RISC to a perfectly complementary mRNA generally results in silencing due to endonucleolytic cleavage of the mRNA specifically by EIF2C2/AGO2. Binding of RISC to a partially complementary mRNA results in silencing through inhibition of translation, and this is independent of endonuclease activity. May inhibit translation initiation by binding to the 7-methylguanosine cap, thereby preventing the recruitment of the translation initiation factor eIF4-E. May also inhibit translation initiation via interaction with EIF6, which itself binds to the 60S ribosomal subunit and prevents its association with the 40S ribosomal subunit. The inhibition of translational initiation leads to the accumulation of the affected mRNA in cytoplasmic processing bodies (P-bodies), where mRNA degradation may subsequently occur. In some cases RISC-mediated translational repression is also observed for miRNAs that perfectly match the 3' untranslated region (3'-UTR). Can also up-regulate the translation of specific mRNAs under certain growth conditions. Binds to the AU element of the 3'-UTR of the TNF (TNF-alpha) mRNA and up-regulates translation under conditions of serum starvation. Also required for transcriptional gene silencing (TGS), in which short RNAs known as antigene RNAs or agRNAs direct the transcriptional repression of complementary promoter regions.very confidentQ9UKV8
Protein argonaute-1 Required for RNA-mediated gene silencing (RNAi). Binds to short RNAs such as microRNAs (miRNAs) or short interfering RNAs (siRNAs), and represses the translation of mRNAs which are complementary to them. Lacks endonuclease activity and does not appear to cleave target mRNAs. May also be required for transcriptional gene silencing (TGS) of promoter regions which are complementary to bound short antigene RNAs (agRNAs).very confidentQ8CJG1
Protein argonaute-2 Required for RNA-mediated gene silencing (RNAi) by the RNA-induced silencing complex (RISC). The 'minimal RISC' appears to include EIF2C2/AGO2 bound to a short guide RNA such as a microRNA (miRNA) or short interfering RNA (siRNA). These guide RNAs direct RISC to complementary mRNAs that are targets for RISC-mediated gene silencing. The precise mechanism of gene silencing depends on the degree of complementarity between the miRNA or siRNA and its target. Binding of RISC to a perfectly complementary mRNA generally results in silencing due to endonucleolytic cleavage of the mRNA specifically by EIF2C2/AGO2. Binding of RISC to a partially complementary mRNA results in silencing through inhibition of translation, and this is independent of endonuclease activity. May inhibit translation initiation by binding to the 7-methylguanosine cap, thereby preventing the recruitment of the translation initiation factor eIF4-E. May also inhibit translation initiation via interaction with EIF6, which itself binds to the 60S ribosomal subunit and prevents its association with the 40S ribosomal subunit. The inhibition of translational initiation leads to the accumulation of the affected mRNA in cytoplasmic processing bodies (P-bodies), where mRNA degradation may subsequently occur. In some cases RISC-mediated translational repression is also observed for miRNAs that perfectly match the 3' untranslated region (3'-UTR). Can also up-regulate the translation of specific mRNAs under certain growth conditions. Binds to the AU element of the 3'-UTR of the TNF (TNF-alpha) mRNA and up-regulates translation under conditions of serum starvation. Also required for transcriptional gene silencing (TGS), in which short RNAs known as antigene RNAs or agRNAs direct the transcriptional repression of complementary promoter regions.confidentQ9QZ81

Prediction of Gene Ontology Terms ?

GO Term ?Description ?Confidence Level ?Parent GO Terms ?
GO:0048471 [CC]perinuclear region of cytoplasmconfidentGO:0005737, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0044444, GO:0044424
GO:0035198 [MF]miRNA bindingconfidentGO:0097159, GO:0003674, GO:0005488, GO:0003676, GO:1901363, GO:0003723
GO:0005634 [CC]nucleusconfidentGO:0043231, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0043229, GO:0044424, GO:0043227, GO:0043226
GO:0030529 [CC]ribonucleoprotein complexconfidentGO:0032991, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0044424
GO:0036099 [BP]female germ-line stem cell maintenanceconfidentGO:0030154, GO:0048468, GO:0050789, GO:0044699, GO:0048863, GO:0048864, GO:0048869, GO:0065007, GO:0048519, GO:0032502, GO:0032501, GO:0019827, GO:0050793, GO:0009987, GO:0050794, GO:0044767, GO:0045596, GO:0045595, GO:0008150, GO:0051093, GO:0030718, GO:0044707, GO:0048856, GO:0044763, GO:0048523
GO:0035278 [BP]negative regulation of translation involved in gene silencing by miRNAconfidentGO:0009892, GO:0080090, GO:0009890, GO:0051246, GO:0031327, GO:0031326, GO:0031324, GO:0031323, GO:0040029, GO:0010629, GO:0050789, GO:0044699, GO:0051248, GO:0010605, GO:0019222, GO:0010608, GO:2000112, GO:2000113, GO:0016458, GO:0065007, GO:0045974, GO:0010468, GO:0060255, GO:0009987, GO:0009889, GO:0050794, GO:0016441, GO:0044763, GO:0031047, GO:0048519, GO:0040033, GO:0032269, GO:0032268, GO:0035194, GO:0035195, GO:0010556, GO:0017148, GO:0006417, GO:0008150, GO:0010558, GO:0048523
GO:0030423 [BP]targeting of mRNA for destruction involved in RNA interferenceconfidentGO:0022607, GO:0009892, GO:0019222, GO:0043933, GO:0010629, GO:0034622, GO:0050789, GO:0071840, GO:0071826, GO:0010605, GO:0010608, GO:0040029, GO:0016043, GO:0065003, GO:0016458, GO:0022618, GO:0065007, GO:0044699, GO:0022613, GO:0016246, GO:0010468, GO:0060255, GO:0009987, GO:0008150, GO:0031047, GO:0048519, GO:0035194, GO:0044085, GO:0016441, GO:0044763
GO:0035196 [BP]production of miRNAs involved in gene silencing by miRNAconfidentGO:0009892, GO:0019222, GO:0090304, GO:0031050, GO:0010629, GO:0006807, GO:0070887, GO:0050789, GO:0044699, GO:0070918, GO:0006139, GO:0051716, GO:0010605, GO:0044260, GO:0071359, GO:0010608, GO:1901360, GO:0040029, GO:0071704, GO:0010467, GO:0065007, GO:0014070, GO:0048519, GO:0010468, GO:0060255, GO:0009987, GO:0006725, GO:0071310, GO:0044763, GO:0031047, GO:0008152, GO:0042221, GO:0010033, GO:0046483, GO:0016070, GO:0044238, GO:0016458, GO:0035194, GO:0035195, GO:1901698, GO:1901699, GO:0034641, GO:0044237, GO:0043170, GO:0043331, GO:0071407, GO:0016441, GO:0008150, GO:0050896, GO:0006396
GO:0007367 [BP]segment polarity determinationconfidentGO:0032502, GO:0007389, GO:0032501, GO:0009880, GO:0044707, GO:0007365, GO:0048856, GO:0044767, GO:0009790, GO:0008150, GO:0003002, GO:0035282, GO:0007350, GO:0007275, GO:0044699
GO:0019899 [MF]enzyme bindingconfidentGO:0003674, GO:0005488, GO:0005515
GO:0030422 [BP]production of siRNA involved in RNA interferenceconfidentGO:0009892, GO:0019222, GO:0090304, GO:0031050, GO:0010629, GO:0006807, GO:0070887, GO:0050789, GO:0044699, GO:0070918, GO:0006139, GO:0051716, GO:0010605, GO:0044260, GO:0071359, GO:0010608, GO:1901360, GO:0040029, GO:0071704, GO:0010467, GO:0065007, GO:0014070, GO:0016246, GO:0010468, GO:0060255, GO:0009987, GO:0006725, GO:0071310, GO:0044763, GO:0031047, GO:0008152, GO:0048519, GO:0042221, GO:0010033, GO:0046483, GO:0016070, GO:0044238, GO:0016458, GO:0035194, GO:0071407, GO:1901698, GO:1901699, GO:0034641, GO:0044237, GO:0043170, GO:0043331, GO:0016441, GO:0008150, GO:0050896, GO:0006396
GO:0007294 [BP]germarium-derived oocyte fate determinationconfidentGO:0048610, GO:0009994, GO:0030154, GO:0019953, GO:0007292, GO:0007293, GO:0009653, GO:0044699, GO:0000003, GO:0048869, GO:0001709, GO:0030706, GO:0007276, GO:0048477, GO:0048646, GO:0032502, GO:0032501, GO:0048609, GO:0032504, GO:0009987, GO:0044767, GO:0022414, GO:0044702, GO:0008150, GO:0022412, GO:0045165, GO:0003006, GO:0048856, GO:0030716, GO:0044763
GO:0006342 [BP]chromatin silencingconfidentGO:0009892, GO:0080090, GO:0009890, GO:0031327, GO:0031326, GO:0031324, GO:0031323, GO:0040029, GO:0010629, GO:0050789, GO:0044699, GO:0010605, GO:0019222, GO:2000112, GO:2000113, GO:0008150, GO:0060255, GO:0016458, GO:0065007, GO:0048519, GO:0045814, GO:0010468, GO:0045934, GO:0019219, GO:0009987, GO:0009889, GO:0050794, GO:0045892, GO:0051171, GO:0051172, GO:2001141, GO:0051253, GO:0051252, GO:0006355, GO:0010556, GO:0044763, GO:0010558, GO:0048523
GO:0007416 [BP]synapse assemblyconfidentGO:0032502, GO:0050808, GO:0044707, GO:0007399, GO:0032501, GO:0009987, GO:0048856, GO:0016043, GO:0008150, GO:0022607, GO:0044763, GO:0071840, GO:0048731, GO:0007275, GO:0044699, GO:0044085
GO:0030727 [BP]germarium-derived female germ-line cyst formationconfidentGO:0048610, GO:0030154, GO:0048468, GO:0019953, GO:0007292, GO:0007293, GO:0009653, GO:0044699, GO:0000003, GO:0048869, GO:0007276, GO:0048477, GO:0048646, GO:0032502, GO:0032501, GO:0048609, GO:0032504, GO:0008283, GO:0009987, GO:0007281, GO:0022414, GO:0008150, GO:0022412, GO:0048134, GO:0048135, GO:0044767, GO:0044702, GO:0003006, GO:0048856, GO:0044763
GO:0006402 [BP]mRNA catabolic processconfidentGO:0090304, GO:0034641, GO:0006807, GO:1901360, GO:1901361, GO:0006139, GO:1901575, GO:0044265, GO:0044260, GO:0071704, GO:0006401, GO:0044238, GO:0009987, GO:0006725, GO:0046700, GO:0008150, GO:0008152, GO:0034655, GO:0009056, GO:0009057, GO:0044248, GO:0046483, GO:0016070, GO:0016071, GO:0044270, GO:0044237, GO:0043170, GO:0019439
GO:0005829 [CC]cytosolprobableGO:0005737, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0044444, GO:0044424
GO:0016442 [CC]RNA-induced silencing complexprobableGO:0032991, GO:0031332, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0044424, GO:0030529
GO:0003743 [MF]translation initiation factor activityprobableGO:0097159, GO:0008135, GO:0003674, GO:0005488, GO:0003676, GO:1901363, GO:0003723
GO:0000932 [CC]cytoplasmic mRNA processing bodyprobableGO:0005737, GO:0035770, GO:0043232, GO:0044464, GO:0043229, GO:0005623, GO:0030529, GO:0005575, GO:0044444, GO:0043228, GO:0044424, GO:0032991, GO:0005622, GO:0043226
GO:0007219 [BP]Notch signaling pathwayprobableGO:0044700, GO:0051716, GO:0008150, GO:0050896, GO:0009987, GO:0050794, GO:0023052, GO:0065007, GO:0044763, GO:0007165, GO:0007166, GO:0007154, GO:0050789, GO:0044699
GO:0005850 [CC]eukaryotic translation initiation factor 2 complexprobableGO:0043234, GO:0005737, GO:0032991, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0044444, GO:0044424
GO:0000956 [BP]nuclear-transcribed mRNA catabolic processprobableGO:0090304, GO:0034641, GO:0006807, GO:1901360, GO:1901361, GO:0006139, GO:1901575, GO:0044265, GO:0044260, GO:0071704, GO:0006401, GO:0006402, GO:0044238, GO:0009987, GO:0006725, GO:0046700, GO:0008150, GO:0008152, GO:0034655, GO:0009056, GO:0009057, GO:0044248, GO:0046483, GO:0016070, GO:0016071, GO:0044270, GO:0044237, GO:0043170, GO:0019439
GO:0035068 [CC]micro-ribonucleoprotein complexprobableGO:0032991, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0044424, GO:0030529
GO:0005844 [CC]polysomeprobableGO:0032991, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0044424, GO:0030529
GO:0000340 [MF]RNA 7-methylguanosine cap bindingprobableGO:0000339, GO:0003674, GO:0005488, GO:0003676, GO:0097159, GO:1901363, GO:0003723
GO:0035279 [BP]mRNA cleavage involved in gene silencing by miRNAprobableGO:0009892, GO:0019222, GO:0090304, GO:0090305, GO:0034641, GO:0006807, GO:0050789, GO:1901360, GO:0006139, GO:0010605, GO:0044260, GO:0010608, GO:0040029, GO:0071704, GO:0010467, GO:0065007, GO:0044699, GO:0048519, GO:0010468, GO:0044238, GO:0060255, GO:0009987, GO:0006725, GO:0044763, GO:0031047, GO:0008152, GO:0046483, GO:0016070, GO:0016071, GO:0016458, GO:0035194, GO:0035195, GO:0010629, GO:0044237, GO:0043170, GO:0016441, GO:0008150, GO:0006379, GO:0006396, GO:0006397
GO:0035197 [MF]siRNA bindingprobableGO:0097159, GO:0003674, GO:0005488, GO:0003676, GO:1901363, GO:0003723
GO:0031054 [BP]pre-miRNA processingprobableGO:0009892, GO:0019222, GO:0050896, GO:0040029, GO:0090304, GO:0031050, GO:0010629, GO:0006807, GO:0070887, GO:0034660, GO:0050789, GO:0044699, GO:0070918, GO:0006139, GO:0051716, GO:0010605, GO:0044260, GO:0071359, GO:0010608, GO:1901360, GO:0010467, GO:0071704, GO:0016458, GO:0065007, GO:0014070, GO:0048519, GO:0010468, GO:0034470, GO:0060255, GO:0009987, GO:0006725, GO:0071310, GO:0044763, GO:0031047, GO:0008152, GO:0042221, GO:0010033, GO:0046483, GO:0016070, GO:0044238, GO:0035194, GO:0035195, GO:0035196, GO:1901699, GO:0034641, GO:0044237, GO:0043170, GO:0043331, GO:0071407, GO:0016441, GO:0008150, GO:1901698, GO:0006396
GO:0045947 [BP]negative regulation of translational initiationprobableGO:0009892, GO:0080090, GO:0009890, GO:0031327, GO:2000112, GO:0031324, GO:0031323, GO:0050789, GO:0051248, GO:0010605, GO:0019222, GO:0010608, GO:0051246, GO:2000113, GO:0065007, GO:0031326, GO:0048519, GO:0010468, GO:0060255, GO:0006446, GO:0009889, GO:0050794, GO:0008150, GO:0032269, GO:0032268, GO:0010556, GO:0017148, GO:0006417, GO:0010558, GO:0048523
GO:0005845 [CC]mRNA cap binding complexprobableGO:0043234, GO:0032991, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0034518, GO:0044424
GO:0003729 [MF]mRNA bindingprobableGO:0097159, GO:0003674, GO:0005488, GO:0003676, GO:1901363, GO:0003723
GO:0070551 [MF]endoribonuclease activity, cleaving siRNA-paired mRNAprobableGO:0016787, GO:0003824, GO:0004518, GO:0004519, GO:0004540, GO:0004521, GO:0016788, GO:0016893, GO:0016891, GO:0003674

Prediction of Enzyme Commission Number ?

No EC number assigned to the protein, probably not an enzyme!


Spatial Structural Prediction

Structural Models Based on Templates

Template: 4F3T, chain A
Confidence level:very confident
Coverage over the Query: 79-480,499-826,843-865
View the alignment between query and template
View the model in PyMOL

Templates for Structure Prediction

ID ?Alignment Graph ?Confidence Level ? View Alignment and Template ?
Query
3pgw, chain Bprobable Alignment | Template Structure